NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 139 filers reported holding NATERA INC in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,038,224 | +56.4% | 18,700 | -0.1% | 0.00% | +100.0% |
Q2 2022 | $664,000 | -90.6% | 18,726 | -89.2% | 0.00% | -80.0% |
Q1 2022 | $7,048,000 | -91.9% | 173,250 | -81.3% | 0.01% | -91.7% |
Q4 2021 | $86,719,000 | +91.8% | 928,608 | +128.9% | 0.06% | +71.4% |
Q3 2021 | $45,207,000 | +196.2% | 405,664 | +201.7% | 0.04% | +169.2% |
Q2 2021 | $15,263,000 | -68.1% | 134,441 | -71.5% | 0.01% | -71.7% |
Q1 2021 | $47,890,000 | +59.1% | 471,630 | +56.0% | 0.05% | +53.3% |
Q4 2020 | $30,093,000 | +757.4% | 302,380 | +522.3% | 0.03% | +650.0% |
Q3 2020 | $3,510,000 | +1579.4% | 48,591 | +1060.2% | 0.00% | – |
Q2 2020 | $209,000 | -97.6% | 4,188 | -98.6% | 0.00% | -100.0% |
Q1 2020 | $8,883,000 | -12.0% | 297,500 | -0.7% | 0.01% | +33.3% |
Q4 2019 | $10,096,000 | +24.1% | 299,657 | +20.8% | 0.01% | +12.5% |
Q3 2019 | $8,137,000 | -49.9% | 248,075 | -57.9% | 0.01% | -46.7% |
Q2 2019 | $16,246,000 | +39.8% | 589,036 | +4.5% | 0.02% | +25.0% |
Q1 2019 | $11,624,000 | – | 563,702 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |